111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. The ProstaScint Study Group (Q74581930)
Jump to navigation
Jump to search
scientific article published on 01 June 1998
Language | Label | Description | Also known as |
---|---|---|---|
English | 111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. The ProstaScint Study Group |
scientific article published on 01 June 1998 |
Statements
111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. The ProstaScint Study Group (English)
D Kahn
R D Williams
M J Manyak
M K Haseman
D W Seldin
J A Libertino
2041-6; discussion 2046-7